Globus Medical, Inc. (GMED)
USD 71.91
(1.13%)
USD 71.91
(1.13%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 848.13 Million USD | 183.68% |
| 2022 | 298.98 Million USD | 26.15% |
| 2021 | 237 Million USD | 3.42% |
| 2020 | 229.15 Million USD | 16.73% |
| 2019 | 196.31 Million USD | 49.57% |
| 2018 | 131.25 Million USD | 21.07% |
| 2017 | 108.4 Million USD | -3.8% |
| 2016 | 112.69 Million USD | 7.06% |
| 2015 | 105.26 Million USD | 15.74% |
| 2014 | 90.94 Million USD | 29.28% |
| 2013 | 70.35 Million USD | 12.9% |
| 2012 | 62.31 Million USD | 31.54% |
| 2011 | 47.36 Million USD | 15.87% |
| 2010 | 40.88 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 717.7 Million USD | -6.85% |
| 2024 Q2 | 770.46 Million USD | -5.6% |
| 2024 Q1 | 816.19 Million USD | -3.77% |
| 2023 Q3 | 904.97 Million USD | 169.69% |
| 2023 Q2 | 335.55 Million USD | 4.52% |
| 2023 FY | 848.13 Million USD | 183.68% |
| 2023 Q1 | 321.03 Million USD | 7.38% |
| 2023 Q4 | 848.13 Million USD | -6.28% |
| 2022 Q3 | 282.4 Million USD | 6.15% |
| 2022 Q4 | 298.98 Million USD | 5.87% |
| 2022 FY | 298.98 Million USD | 26.15% |
| 2022 Q1 | 253.88 Million USD | 7.12% |
| 2022 Q2 | 266.04 Million USD | 4.79% |
| 2021 Q3 | 234.36 Million USD | 1.37% |
| 2021 Q4 | 237 Million USD | 1.12% |
| 2021 Q2 | 231.2 Million USD | -0.34% |
| 2021 FY | 237 Million USD | 3.42% |
| 2021 Q1 | 232 Million USD | 1.25% |
| 2020 Q1 | 208.45 Million USD | 6.18% |
| 2020 Q2 | 224.45 Million USD | 7.68% |
| 2020 Q3 | 231.85 Million USD | 3.3% |
| 2020 Q4 | 229.15 Million USD | -1.17% |
| 2020 FY | 229.15 Million USD | 16.73% |
| 2019 Q2 | 173.04 Million USD | 20.69% |
| 2019 Q1 | 143.38 Million USD | 9.24% |
| 2019 Q3 | 187.06 Million USD | 8.1% |
| 2019 FY | 196.31 Million USD | 49.57% |
| 2019 Q4 | 196.31 Million USD | 4.95% |
| 2018 FY | 131.25 Million USD | 21.07% |
| 2018 Q1 | 107.58 Million USD | -0.76% |
| 2018 Q4 | 131.25 Million USD | 5.53% |
| 2018 Q3 | 124.37 Million USD | 8.38% |
| 2018 Q2 | 114.75 Million USD | 6.67% |
| 2017 Q3 | 111.46 Million USD | 0.32% |
| 2017 Q1 | 113.03 Million USD | 0.31% |
| 2017 FY | 108.4 Million USD | -3.8% |
| 2017 Q4 | 108.4 Million USD | -2.74% |
| 2017 Q2 | 111.1 Million USD | -1.71% |
| 2016 Q3 | 115.6 Million USD | 10.72% |
| 2016 FY | 112.69 Million USD | 7.06% |
| 2016 Q4 | 112.69 Million USD | -2.52% |
| 2016 Q2 | 104.41 Million USD | -0.69% |
| 2016 Q1 | 105.14 Million USD | -0.11% |
| 2015 FY | 105.26 Million USD | 15.74% |
| 2015 Q3 | 105.7 Million USD | 4.61% |
| 2015 Q2 | 101.04 Million USD | 2.12% |
| 2015 Q1 | 98.94 Million USD | 8.8% |
| 2015 Q4 | 105.26 Million USD | -0.42% |
| 2014 FY | 90.94 Million USD | 29.28% |
| 2014 Q4 | 90.94 Million USD | 17.45% |
| 2014 Q3 | 77.43 Million USD | 1.4% |
| 2014 Q2 | 76.36 Million USD | 5.32% |
| 2014 Q1 | 72.5 Million USD | 3.07% |
| 2013 Q4 | 70.35 Million USD | -1.19% |
| 2013 FY | 70.35 Million USD | 12.9% |
| 2013 Q1 | 66.86 Million USD | 7.31% |
| 2013 Q2 | 71.35 Million USD | 6.71% |
| 2013 Q3 | 71.19 Million USD | -0.22% |
| 2012 Q4 | 62.31 Million USD | 9.24% |
| 2012 Q2 | 53.12 Million USD | 7.82% |
| 2012 Q1 | 49.27 Million USD | 4.02% |
| 2012 FY | 62.31 Million USD | 31.54% |
| 2012 Q3 | 57.03 Million USD | 7.37% |
| 2011 FY | 47.36 Million USD | 15.87% |
| 2011 Q4 | 47.36 Million USD | 0.0% |
| 2010 FY | 40.88 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 87.091% |
| Allurion Technologies Inc. | 6.17 Million USD | -13643.883% |
| Artivion, Inc. | 81.97 Million USD | -934.614% |
| Avanos Medical, Inc. | 163.2 Million USD | -419.691% |
| Butterfly Network, Inc. | 75.83 Million USD | -1018.366% |
| Butterfly Network, Inc. | 75.83 Million USD | -1018.366% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | -8.663% |
| Boston Scientific Corporation | 2.48 Billion USD | 65.856% |
| CONMED Corporation | 318.32 Million USD | -166.438% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 27.398% |
| Paragon 28, Inc. | 98.06 Million USD | -764.897% |
| Glaukos Corporation | 41.98 Million USD | -1920.042% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -2402.981% |
| Integer Holdings Corporation | 239.71 Million USD | -253.808% |
| Medtronic plc | 5.21 Billion USD | 83.743% |
| Myomo, Inc. | 1.8 Million USD | -46926.987% |
| Nevro Corp. | 118.67 Million USD | -614.664% |
| Owlet, Inc. | 6.49 Million USD | -12962.298% |
| Penumbra, Inc. | 388.02 Million USD | -118.579% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 64.587% |
| STERIS plc | 674.53 Million USD | -25.736% |
| Stryker Corporation | 4.84 Billion USD | 82.487% |
| Vapotherm, Inc. | 22.96 Million USD | -3592.681% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 64.442% |